Highlights PTC Therapeutics, Inc.

Equities

PTCT

US69366J2006

Real-time Estimate Cboe BZX Other stock markets 17:20:57 09/05/2024 BST			5-day change	1st Jan Change
31.04 ^USD	-0.31%		-7.85%	+12.41%

04-30	North American Morning Briefing : More Earnings -2-	DJ
04-29	Morgan Stanley Upgrades PTC Therapeutics to Equalweight From Underweight, Adjusts PT to $30 From $28	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : More Earnings -2-	04-30	DJ
Sector Update: Health Care Stocks Edge Higher Late Afternoon	04-26	MT
Sector Update: Health Care	04-26	MT
PTC Therapeutics Shares Rise After Better-Than-Expected Q1 Results	04-26	MT
Earnings Flash (PTCT) PTC THERAPEUTICS Posts Q1 Revenue $210.1M, vs. Street Est of $163.8M	04-25	MT
PTC Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
PTC Therapeutics, Inc. Reaffirms Earnings Guidance for the Year 2024	04-25	CI
PTC Therapeutics, Inc. Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA	03-28	CI
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza? as a Treatment for AADC Deficiency	03-19	CI
PTC Therapeutics Shares Jump Following Q4 Results	03-01	MT
PTC Therapeutics Q4 Loss Narrows, Sales Up; Sets Guidance; Shares Slump After-Hours	02-29	MT
PTC Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
PTC Therapeutics, Inc. Provides Earnings Guidance for the Year 2024	02-29	CI
Earnings Flash (PTCT) PTC THERAPEUTICS Posts Q4 Revenue $307.1M, vs. Street Est of $317.9M	02-29	MT
PTC Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-29	CI
Global markets live: LVMH, Intel, Tesla, Salesforce, Eli Lilly...	01-26
Inflation is just the icing on the cake	01-26
Stocks to Watch : Intel, PTC Therapeutics, KLA	01-25	DJ
Europe to withdraw PTC Therapeutics' rare muscle disorder drug	01-25	RE
PTC Therapeutics' muscle disorder drug fails to secure EU regulator backing	01-25	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights PTC Therapeutics, Inc.

Equities

PTCT

US69366J2006

Highlights

Filters